[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.127.188. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1977

Importance of Myocardial Antibodies in Heart Disease

Author Affiliations

Maywood, Ill

Arch Intern Med. 1977;137(5):570-572. doi:10.1001/archinte.1977.03630170008004
Abstract

Clinicians have long recognized the importance of immune mechanisms in certain cardiovascular syndromes. Myocardial autoantibodies (HAb) occur in a number of cardiac states as a result of myocardial injury due to infection, infarction, surgery, or trauma to the heart or pericardium. Cavelti's demonstration of cross-reactivity of the rat heart and Streptococcus antigen in acute rheumatic fever went unheralded for a decade before HAb were implicated in the pathogenesis of this disease.1 Kaplan and Meyeserian's work confirmed that HAb occurred after streptococcal infection in response to a cross-reactive antigen of group A Streptococcus to myofibrils.2 The importance of HAb in the progression of rheumatic heart disease was studied by Ehrenfeld et al by using tanned RBC hemagglutinins in a variety of cardiac and noncardiac diseases.3 His studies indicated HAb was not a cause but a consequence of tissue destruction. High titers of HAb did not lead to histologic

First Page Preview View Large
First page PDF preview
First page PDF preview
×